<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>18719798</identifier>
<setSpec>0104-4230</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Alfonso, John Edwin Feliciano</dc:author>
<dc:author>Ariza, Iván Darío Sierra</dc:author>
<dc:description xml:lang="en">After having reached the objective for the LDL cholesterol levels, it becomes imperative to reach the objective for HDL cholesterol, known for its anti-atherogenic properties, generally confirmed in many epidemiological studies. This review deals, in a clear and concise manner, with the different alternatives available in daily clinical practice to raise the HDL cholesterol levels of patients, to achieve better outcomes in terms of morbidity and mortality in cardiovascular disease.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:date>2008 Jul-Aug </dc:date>
<dc:title xml:lang="es">Elevando el colesterol HDL: ¿Cuál es la mejor estrategia?</dc:title>
<dc:title xml:lang="en">[Raising HDL cholesterol: which is the best strategy?].</dc:title>
<dc:publisher>Revista da Associacao Medica Brasileira (1992)</dc:publisher>
</metadata>
</record>
</pubmed-document>
